Commonwealth Coat of Arms of Australia

 

 

PB 34 of 2025

National Health (Price and Special Patient Contribution) Amendment Determination (No. 3) 2025

I, Rebecca Richardson, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination:

Dated        27 March 2025

REBECCA RICHARDSON

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health and Aged Care

1  Name...................................................1

2  Commencement............................................1

3  Authority................................................1

4  Schedules................................................1

Schedule 1—Amendments 2

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022) 2

 

  This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination (No. 3) 2025.

  This instrument may also be cited as PB 34 of 2025.

 (1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.

 

Commencement information

Column 1

Column 2

Column 3

Provisions

Commencement

Date/Details

1.  The whole of this instrument

1 April 2025

 

Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.

 (2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.

  This instrument is made under section 85B of the National Health Act 1953.

  Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1 – Amendments

 

National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)

  1.                  Schedule 1 – entry for Clomipramine

Omit

Clomipramine

Tablet containing clomipramine hydrochloride 25 mg

Oral

Anafranil 25

50

5.52

9.63

 

Insert

Clomipramine

Tablet containing clomipramine hydrochloride 25 mg

Oral

Anafranil 25

50

4.65

8.11

  1.                  Schedule 1 – after entry for Clomipramine

Insert

Clonazepam

Tablet 500 micrograms

Oral

Rivotril

100

3.15

4.01

  1.                  Schedule 1 – entry for Dabigatran etexilate

Omit

Dabigatran etexilate

Capsule 110 mg (as mesilate)

Oral

Pradaxa

60

6.19

46.44

 

Capsule 150 mg (as mesilate)

Oral

Pradaxa

60

36.88

46.18

 

Insert

Dabigatran etexilate

Capsule 110 mg (as mesilate)

Oral

Pradaxa

60

5.53

41.49

 

Capsule 150 mg (as mesilate)

Oral

Pradaxa

60

32.94

41.25

  1.                  Schedule 1 – entry for Dosulepin

Omit

Dosulepin

Capsule containing dosulepin hydrochloride 25 mg

Oral

Dothep 25

50

2.89

4.70

 

Tablet containing dosulepin hydrochloride 75 mg

Oral

Dothep 75

30

2.89

4.70

 Insert

Dosulepin

Tablet containing dosulepin hydrochloride 25 mg

Oral

Dothep 25

50

2.89

4.70

 

  1.                  Schedule 1 – entry for Esomeprazole and clarithromycin and amoxicillin

Omit

Esomeprazole and clarithromycin and amoxicillin

Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)

Oral

Nexium Hp7

1

23.65

28.26

 

Insert

Esomeprazole and clarithromycin and amoxicillin

Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate)

Oral

Nexium Hp7

1

20.96

24.72

  1.                  Schedule 1 – entry for Exemestane

Omit

Exemestane

Tablet 25 mg

Oral

Aromasin

30

42.25

45.30

 

Insert

Exemestane

Tablet 25 mg

Oral

Aromasin

30

35.19

37.73

  1.                  Schedule 1 – entry for Ezetimibe and rosuvastatin

Omit

Ezetimibe and rosuvastatin

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)

Oral

Rosuzet Composite Pack

1

6.75

9.42

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium)

Oral

Rosuzet Composite Pack

1

8.04

10.80

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium)

Oral

Rosuzet Composite Pack

1

7.88

10.65

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium)

Oral

Rosuzet Composite Pack

1

8.94

11.81

Insert

Ezetimibe and rosuvastatin

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium)

Oral

Rosuzet Composite Pack

1

10.75

13.42

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium)

Oral

Rosuzet Composite Pack

1

12.04

14.81

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium)

Oral

Rosuzet Composite Pack

1

13.88

16.65

 

Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium)

Oral

Rosuzet Composite Pack

1

13.59

16.46

  1.                  Schedule 1 – omit entry for Ezetimibe with atorvastatin
  2.                  Schedule 1 – entry for Lansoprazole

Omit

Lansoprazole

Tablet 15 mg (orally disintegrating)

Oral

Zoton FasTabs

28

3.42

7.89

 

Tablet 30 mg (orally disintegrating)

Oral

Zoton FasTabs

28

4.48

9.35

 

Insert

Lansoprazole

Tablet 15 mg (orally disintegrating)

Oral

Zoton FasTabs

28

3.42

7.89

 

Tablet 30 mg (orally disintegrating)

Oral

Zoton FasTabs

28

4.00

8.35

  1.              Schedule 1 – entry for Levothyroxine

Omit

Levothyroxine

Tablet containing 50 micrograms anhydrous levothyroxine sodium

Oral

Oroxine

200

9.39

10.61

 

Tablet containing 75 micrograms anhydrous levothyroxine sodium

Oral

Oroxine

200

9.55

10.78

 

Tablet containing 100 micrograms anhydrous levothyroxine sodium

Oral

Oroxine

200

9.73

10.95

 

Tablet containing 200 micrograms anhydrous levothyroxine sodium

Oral

Oroxine

200

11.41

12.63

 

Insert

Levothyroxine

Tablet containing 50 micrograms anhydrous levothyroxine sodium

Oral

Oroxine

200

8.03

9.07

 

Tablet containing 75 micrograms anhydrous levothyroxine sodium

Oral

Oroxine

200

8.17

9.22

 

Tablet containing 100 micrograms anhydrous levothyroxine sodium

Oral

Oroxine

200

8.32

9.36

 

Tablet containing 200 micrograms anhydrous levothyroxine sodium

Oral

Oroxine

200

9.76

10.80

  1.              Schedule 1 – entry for Mefenamic acid

Omit

Mefenamic acid

Capsule 250 mg

Oral

Ponstan

50

5.79

7.72

 

Insert

Mefenamic acid

Capsule 250 mg

Oral

Ponstan

50

4.56

6.08

  1.              Schedule 1 – omit entry for Methylphenidate
  2.              Schedule 1 – entry for Naproxen

Omit

Naproxen

Tablet 1 g (sustained release)

Oral

Naprosyn SR1000

28

5.41

7.60

 

Tablet 750 mg (sustained release)

Oral

Naprosyn SR750

28

4.06

6.34

 

Tablet containing naproxen sodium 550 mg

Oral

Anaprox 550

50

4.55

7.26

 

Insert

Naproxen

Tablet 1 g (sustained release)

Oral

Naprosyn SR1000

28

6.10

8.29

 

Tablet 750 mg (sustained release)

Oral

Naprosyn SR750

28

4.54

6.79

 

Tablet containing naproxen sodium 550 mg

Oral

Anaprox 550

50

5.15

7.82

  1.              Schedule 1 – entry for Olmesartan with amlodipine

Omit

Olmesartan with amlodipine

Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate)

Oral

Sevikar 20/5

30

3.62

6.41

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate)

Oral

Sevikar 40/5

30

5.18

7.97

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate)

Oral

Sevikar 40/10

30

5.56

8.35

 

Insert

 

Olmesartan with amlodipine

Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate)

Oral

Sevikar 20/5

30

3.62

7.34

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate)

Oral

Sevikar 40/5

30

5.18

7.97

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate)

Oral

Sevikar 40/10

30

5.56

8.35

 

 

  1.              Schedule 1 – entry for Perindopril

Omit

Perindopril

Tablet containing perindopril arginine 2.5 mg

Oral

Coversyl 2.5mg

30

2.50

11.58

 

Tablet containing perindopril arginine 5 mg

Oral

Coversyl 5mg

30

3.16

11.95

 

Tablet containing perindopril arginine 10 mg

Oral

Coversyl 10mg

30

4.07

13.30

 

Insert

Perindopril

Tablet containing perindopril arginine 2.5 mg

Oral

Coversyl 2.5mg

30

2.50

11.58

 

Tablet containing perindopril arginine 5 mg

Oral

Coversyl 5mg

30

3.16

11.95

 

Tablet containing perindopril arginine 10 mg

Oral

Coversyl 10mg

30

4.00

13.07